Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Clinical trial NCT00470054 · COMPLETED

Trial details

NCT number: NCT00470054
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer Limited Stage Small Cell Lung Cancer Recurrent Small Cell Lung Cancer

Start date: 2007-04-01
Primary completion: 2009-02-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.